Age-dependent association of cannabis use with risk of psychotic disorder
McDonald AJ, Kurdyak P, Rehm J, Roerecke M, Bondy SJ. Psychol Med. 2024; May 22 [Epub ahead of print].
Publications
Sex-related differences in dispensation of rheumatic medications in older patients with inflammatory arthritis: A population-based study
Tarannum S, Widdifield J, Wu CF, Johnson SR, Rochon P, Eder L. J Rheumatol. 2024; May 15 [Epub ahead of print].
The effect of COVID-19 vaccination on outpatient antibiotic prescribing in older adults: a self-controlled risk-interval study
Jorgensen SCJ, Brown K, Clarke AE, Schwartz KL, Maxwell C, Daneman N, Kwong JC, MacFadden DR. Clin Infect Dis. 2024; May 3 [Epub ahead of print].
Comparing measures of adherence and persistence to P2Y12 inhibitors in acute coronary syndromes
Moon J, Ozaki AF, Chong A, Sud M, Fang J, Austin PC, Ko DT, Jackevicius CA. Am J Cardiol. 2024; S0002-9149(24)00329-1. Epub 2024 Apr 30.
Association between opioid use disorder and palliative care: a cohort study using linked health administrative data in Ontario, Canada
Lau J, Scott MM, Everett K, Gomes T, Tanuseputro P, Jennings S, Bagnarol R, Zimmermann C, Isenberg SR. CMAJ. 2024;
Hyponatremia-associated hospital visits are not reduced by early electrolyte testing in older adults starting antidepressants
Lane NE, Bai L, Seitz DP, Juurlink DN, Paterson JM, Guan J, Stukel TA. J Am Geriatr Soc. 2024; Apr 25 [Epub ahead of print].
The relationship between relational continuity and family physician follow-up after an antidepressant prescription in older adults: a retrospective cohort study
Rudoler D, Lane N, Grudniewicz A, Ling V, Snadden D, Stukel TA. BMC Prim Care. 2024; 25(1):125. Epub 2024 Apr 22.
Characteristics of opioid toxicity deaths among adolescents and young adults in Ontario prior to and during the COVID-19 pandemic
Akbar S, Iacono A, Yang J, Antoniou T, Juurlink D, Sheikh H, Kurdyak P, Wu F, Cheng C, Leece P, Kolla G, Emblem J, Shearer D, Gomes T. J Adolesc Health. 2024; Apr 9 [Epub ahead of print].
On-time denosumab dosing recovered rapidly during the COVID-19 pandemic, yet remains suboptimal
Rzepka AM, Cheung AM, Kim S, Gomes T, Cadarette SM. JBMR Plus. 2024; 8(5):ziae027. Epub 2024 April 9, 2024.
Alpha-1 adrenergic antagonists and the risk of hospitalization or death in non-hospitalized patients with COVID-19: a population-based study
Antoniou T, McCormack D, Tadrous M, Gomes T. Fundam Clin Pharmacol. 2024; Apr 4 [Epub ahead of print].